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ABSTRACT
Objective To undertake a case review of deaths 
in a 6- week period during the COVID-19 pandemic 
commencing with the first death in the hospital from 
COVID-19 on 12th of March 2020 and contrast this with 
the same period in 2019.
Setting A large London teaching hospital.
Participants Three groups were compared: group 
1—COVID-19- associated deaths in the 6- week period 
(n=243), group 2—non- COVID deaths in the same period 
(n=136) and group 3—all deaths in a comparison period 
of the same 6 weeks in 2019 (n=194).
Primary and secondary outcome measures This was 
a descriptive analysis of death case series review and 
as such no primary or secondary outcomes were pre- 
stipulated.
Results Deaths in patients from the Black, Asian and 
minority ethnic (BAME) communities in the pandemic 
period significantly increased both in the COVID-19 group 
(OR=2.43, 95% CI=1.60–3.68, p<0.001) and the non- 
COVID group (OR=1.76, 95% CI=1.09–2.83, p=0.02) 
during this time period and the increase was independent 
of differences in comorbidities, sex, age or deprivation. 
While the absolute number of deaths increased in 
2020 compared with 2019, across all three groups 
the distribution of deaths by age was very similar. Our 
analyses confirm major risk factors for COVID-19 mortality 
including male sex, diabetes, having multiple comorbidities 
and background from the BAME communities.
Conclusions There was no evidence of COVID-19 
deaths occurring disproportionately in the elderly 
compared with non- COVID deaths in this period in 
2020 and 2019. Deaths in the BAME communities were 
over- represented in both COVID-19 and non- COVID 
groups, highlighting the need for detailed research in 
order to fully understand the influence of ethnicity on 
susceptibility to illness, mortality and health- seeking 
behaviour during the pandemic.
INTRODUCTION
COVID-19 emerged in Wuhan, China, at 
the end of 2019, before spreading around 
the world with devastating effects. In the 
city of Nembro, Northern Italy, the all- 
monthly all- cause mortality rose from 10 
per 1000 person- years to a peak of 154.4 
per 1000 person- years.1 In New York, over 
an 8- week period, a total of 32 107 deaths 
were reported, of which 24 172 were found 
to be in excess of the seasonal expected 
baseline.2 The first case was recorded in the 
UK on 31st of January 2020 and in London 
on the 12th of February 2020. The first UK 
fatality was reported on the 28th of February 
2020. As the pandemic spread across the 
world, a number of at- risk groups have been 
identified: Black, Asian and minority ethnic 
(BAME) groups,3 men, the elderly and those 
with pre- existing comorbidities, particularly 
Strengths and limitations of this study
 ► Large timely analysis from detailed case note re-
view by independent medical examiners capturing 
data from all deaths (intensive care and ward- based 
care) in the hospital.
 ► All swab- positive deaths associated with COVID-19 
were included and compared with non- COVID 
deaths and historical data from the previous year.
 ► We identified important ethnic differences with in-
creased mortality in the Black, Asian and minority 
ethnic communities in both COVID-19 and non- COVID 
deaths in the early weeks of the pandemic.
 ► The principle limitation was that this was a single- 
centre study and focused on hospital mortality data 
alone and not out of hospital deaths and therefore 
the full picture of regional mortality could not be 
ascertained.
 ► All such studies are limited by the quality of the clin-
ical records and in particular detailed data about the 
demographics of the whole admission population.
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diabetes mellitus, hypertension and ischaemic heart 
disease.4 5
The BAME communities make up 14% of the popula-
tion of England and Wales in the 2011 England and Wales 
census, but represent 17% of deaths as of the 28th of 
April 2020 in England6 and 35% of those who have been 
admitted to intensive care units as of the 1st of May 2020.7 
The UK government has committed to Public Health 
England undertaking a review investigating why BAME 
communities are disproportionately affected. The BAME 
communities are known to have a higher prevalence of 
specific cardiometabolic risk factors, including diabetes, 
hypertension, ischaemic heart disease and stroke.8 The 
BAME communities also experience higher rates of 
poverty. In London, the poorest boroughs (Newham, 
Brent and Hackney) have had the highest COVID-19 
mortality per 100 000 population. Conversely, the BAME 
communities are, on average, younger than the white 
population in the UK. In the 2011 England and Wales 
census, the median age by ethnic group was: white, 41 
years; Asian, 29 years and Black, 30 years.9 Given the 
mortality from COVID-19 increases significantly with age, 
the over- representation of the BAME communities when 
age adjusted, is likely to be even more pronounced.
COVID-19 mortality is significantly higher in men, 
whose life expectancy is also shorter than women (79.3 
years vs 82.9 years).10 The reason for the excess mortality 
in men is also uncertain and it has been postulated that 
it is related to the increased prevalence of comorbidities 
in men than women, and to the higher smoking rates 
(16.5% vs 13.0%).11
St George’s University Hospital NHS Foundation Trust 
is one of the largest hospitals in the UK and is based in 
South West London. It serves a local catchment population 
of 560 000 and specialist services to 3.4 million people in 
South West London. A national system of medical exam-
iners is being rolled out in England and Wales to provide 
much- needed scrutiny of deaths, support for bereaved 
families, to improve patient safety, and to improve death 
certification and data accuracy. This service reviews case 
notes and agrees cause of death with the clinical teams. 
The service is in a unique position to collect timely 
prospective and consistent mortality data. The first death 
from COVID-19 occurred on the 12th of March 2020. 
In this paper the medical examiner team reviewed the 6 
weeks of mortality data at St George’s Hospital from this 
date, comparing it with deaths taking place in the same 6 
weeks of 2019 as a comparison group.
METHODS
Participants
The mortality data for deaths occurring at St George’s 
Hospital for the 6 weeks commencing 12th of March 2020 
were collated. Deaths in this period were divided into two 
groups. Group 1 were the COVID-19- associated deaths 
where COVID-19 had been identified by a positive swab, 
and in all cases COVID-19 was declared on the death 
certificate. Group 2 were non- COVID deaths in the same 
period with no patients in this group having swabbed 
positive for COVID-19. The comparison groups were 
patients who had died at St George’s during the same 6 
weeks from 12th of March in 2019.
Data available included sex, age, postcode of residence 
at time of death, declared ethnicity and cause of death. 
The electronic medical record was reviewed to identity 
the presence of specific comorbidities: diabetes mellitus, 
ischaemic heart disease and hypertension. Ethnicity was 
categorised as White, Black, Asian, Other (including 
mixed) and not specified or known.
The postcode was used to identify the Index of 
Multiple Deprivation (IMD) decile using the 2019 IMD 
data. England is divided into 32 844 Lower- layer Super 
Output Areas (LSOAs) and the relative level of depriva-
tion in each LSOA has been determined using a multi- 
faceted metric.12 The LSOAs are ranked from first (most 
deprived) to last, and then turned into deciles of depri-
vation, with decile 1 being the most deprived and decile 
10 the least.
Patient and public involvement
This was a retrospective analysis of mortality in a large 
London centre in the first phases of the COVID-19 
pandemic. This was a description of the data and analysis 
of routinely collected data. Patients and the public will be 
involved in dissemination of these data in order to inform 
local management and policy.
Statistical analyses
Data were anonymised prior to analysis. There were no 
missing data for age or sex. The IMD was unknown in 
two cases and ethnicity either not known or not stated 
for 103 of the 573 cases analysed. Cross tabulations of the 
risk factors for COVID-19 mortality were undertaken by 
group. Statistical comparisons were made using Χ2 tests 
for categorical variables and t- tests (normally distributed) 
or Wilcoxon rank- sum tests (non- normally distributed 
such as age) for continuous variables as appropriate. An 
adjusted logistic analysis was undertaken to establish the 
independent effects of ethnicity, sex, comorbidities and 
deprivation on COVID-19 mortality, adjusting for age. 
Analyses were undertaken using Stata V.15 (Stata Corp, 
Texas, USA).
RESULTS
In the 6- week period from 12th of March 2020 there were 
243 deaths among patients with confirmed COVID-19 
(group 1) and 136 deaths from non- COVID causes (group 
2) at St George’s Hospital (table 1). The total number of 
deaths in this period in 2020, 379, significantly exceeded 
the 194 deaths in the same 6 weeks in 2019 (group 3) 
(comparison of average weekly death rates, p<0.001). The 
COVID-19 weekly death rate alone exceeded the 2019 
weekly death rate. In contrast, there was a marked reduc-
tion in the non- COVID weekly death rate in 2020 and it 
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Table 1 Demographics and risk factor distribution by group
COVID-19 2020
(group 1)
Non- COVID 2020
(group 2)
2019
(group 3)
1 versus 2 2 versus 3
Deaths
  Week 1 8 30 45
  Week 2 25 28 24
  Week 3 55 22 31
  Week 4 65 24 32
  Week 5 55 18 31
  Week 6 35 14 31
  Weekly average 41 23 32
  Total 243 0.40 136 0.03 194
Sex
  Male 67% (162) <0.001 53% (72) 0.28 50% (97)
IMD decile
  1 1% (2) 0% (0) 1% (2)
  2 5% (13) 4% (60 3% (6)
  3 10% (24) 12% (16) 9% (17)
  4 18% (43) 12% (16) 10% (19)
  5 11% (26) 10% (14) 10% (20)
  6 15% (37) 15% (20) 19% (37)
  7 17% (41) 11% (15) 11% (22)
  8 7% (17) 7% (9) 9% (17)
  9 8% (19) 16% (21) 10% (19)
  10 9% (21) 0.047 13% (18) 0.62 18% (34)
  1–5 44% (108) 0.02 38% (52) 0.33 33% (64)
Ethnicity
  Non- White 69% (167) <0.001 58% (79) 0.04 46% (90)
Previous comorbidities
  Diabetes mellitus 33% (79) <0.001 20% (27) 0.43 16% (32)
  Hypertension 53% (129) 0.02 55% (75) 0.02 42% (81)
  Ischaemic heart disease 16% (40) 0.38 32% (44) <0.001 13% (26)
Comorbidities (#)*
  0 37% (89) 33% (45) 46% (90)
  1 31% (76) 36% (49) 38% (73)
  2 26% (62) 21% (29) 14% (27)
  3 7% (16) 0.001 10% (13) 0.002 2% (4)
Age (median years)
  White 81 0.93 76 0.35 81
  Asian 71 0.95 74 0.71 67
  Black 77 0.33 77 0.37 80
  Other 76 0.90 77 0.95 77
  Not- known/recorded 76 0.54 68 0.47 72
  All 76 0.56 76 0.28 78
P value comparisons of group 1 or 2 versus group 3.
*Number of comorbidities from diabetes mellitus, hypertension and ischaemic heart disease (range 0–3).
IMD, Index of Multiple Deprivation.
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was significantly lower than the 2019 weekly death rate 
(p=0.03).
That the lower weekly death rate from non- COVID 
causes in 2020 was not an anomaly is demonstrated in 
figure 1, where the average weekly death rate in the 6 
weeks preceding 12th of March 2020, 29 deaths/week, 
was similar to the 2019 weekly average death rate of 32 
deaths/week (p=0.26). Furthermore, while the COVID-19 
weekly deaths peaked in the week commencing 2nd of 
April 2020, the weekly death rate from non- COVID causes 
continued to diminish across the 6- week period, reaching 
less than half (14 deaths) of the normal weekly rate by the 
final week of the period.
Sex
While there was no significant difference in the sex 
ratio for non- COVID deaths in 2020 (group 2) or 2019 
(group 3), men were significantly more likely to have 
died of COVID-19 (67% (162/243), p<0.0001) (table 1). 
The excess of men among those dying of COVID-19 was 
present in every ethnic group (data not shown).
Age distribution
There was no significant difference in the median age 
of death between the three groups (table 1). Looking at 
the distribution of ages within each group, the distribu-
tion was notably similar in all three groups (figure 2A). 
Hence, there was no suggestion that the elderly were 
disproportionately represented in the hospital COVID-19 
deaths compared with deaths from other causes in either 
2020 or 2019.
The median age of death in the three groups combined, 
varied with ethnicity. The median age of death among the 
573 cases was: white, 80 years; Asian, 71 years (p<0.001 vs 
white); Black, 77 years (p=0.05 vs white); Other, 76 years 
and Not known/not stated, 74 years. In contrast, there 
was no significant difference within ethnic groups in 
median age of death comparing those dying of COVID-19 
or non- COVID causes in 2020, with the median age of 
death in 2019 (table 1).
Declared ethnicity
Compared with deaths in 2019 (46% (90/194) non- 
white), non- white ethnic groups were significantly 
over- represented among non- COVID deaths in 2020 
(58% (79/136), p=0.04), but particularly among 
COVID-19 deaths (69% (167/243), p<0.001). This over- 
representation was most marked among the Asian and 
Black ethnic groups (figure 2B).
Deprivation
There was a difference in IMD distribution between 
the three groups (table 1). While non- COVID deaths 
in 2019 and 2020 had broadly the same IMD distribu-
tion, COVID-19 deaths in 2020 were more likely to have 
occurred in those living in the top five deciles of depri-
vation (44% (108/243) of COVID-19 deaths in 2020 
compared with 33% (64/194) of deaths in 2019, p=0.02).
Causes of death
Given that there had been a significant reduction in the 
number of deaths, excluding COVID-19, between 2019 
and 2020, we explored what the underlying cause of 
death had been in groups 2 and 3 (figure 3). St George’s 
is a regional stroke and interventional cardiology centre 
and one of London’s four trauma centres. Hence, it 
was particularly notable to see a large reduction in the 
number of deaths from stroke (60% reduction), but not 
from heart disease (10%) or trauma (0%).
Comorbidities
Diabetes mellitus was significantly more common 
among patients who died with COVID-19 in 2020 (33% 
(79/243), p<0.001), compared with deaths in 2019 (16% 
(32/194)). Hypertension was more prevalent in both 
the COVID-19 mortality group (53% (129/243), p=0.02) 
and the non- COVID deaths in 2020 (55% (75/136), 
p=0.02), compared with deaths in 2019 (42% (81/194)). 
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Figure 1 Weekly death rate in the 6 weeks up to the first 
COVID-19 death followed by the first 6 weeks' mortality 
during the pandemic at St George’s Hospital.
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(B) in each of the three groups. Group 1: COVID-19 deaths 
(2020); group 2: non- COVID deaths (2020); group 3: all 
deaths (2019).
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Pre- existing ischaemic heart disease was significantly more 
prevalent among the non- COVID 2020 deaths compared 
with the deaths in 2019 (32% (44/136) vs 13% (26/194), 
p<0.001) (table 1). Multiple comorbidities were signifi-
cantly more likely in those dying from COVID-19 or non- 
COVID causes in 2020, compared with deaths in 2019 
(table 1).
Adjusted analysis: COVID-19 deaths 2020 compared with 2019
The logistic model included ethnic group, deprivation 
(being in the top five deciles of deprivation), sex, and 
comorbidities and adjusted for age. In the left panel 
of figure 4, the comorbidities were included individ-
ually. Compared with 2019, COVID-19 deaths were 
increased across the ethnic groups: Asian (ORadj=3.62, 
95% CI=1.84–7.11, p<0.001); Black (ORadj=2.91, 95% CI= 
1.43–5.91, p=0.003) and Other ethnicity (ORadj=3.01, 95% 
CI=1.61–5.64, p<0.001). Deprivation (IMD>median) was 
associated with a non- significant increase in likelihood of 
COVID-19 death, compared with 2019.
Among the individual risk factors, diabetes mellitus 
significantly increased the risk of COVID-19 death 
compared with 2019 (ORadj=1.76, 95% CI=1.05–2.94, 
p=0.03). There was no significant association with either 
hypertension or ischaemic heart disease. Male sex 
remained significantly associated with COVID-19 death 
(ORadj=2.00, 95% CI=1.32–3.03, p=0.001).
Replacing the ethnic subgroups with ethnicity dichoto-
mised to white/non- white resulted in non- white ethnicity 
being significantly associated with COVID-19 mortality 
(ORadj=2.43, 95% CI=1.60–3.68, p<0.001).
In the right- hand panel of figure 4, the comorbidities 
score was included. Compared with deaths in 2019, there 
was a dose–response relationship between likelihood of 
death from COVID-19 and increasing number of comorbid-
ities: baseline, no comorbidities (OR=1.0), one comorbidity 
(ORadj=0.90, 95% CI=0.56–1.44, p=0.67), two comorbidities 
(ORadj=1.75, 95% CI=0.99–3.10, p=0.06) and three comor-
bidities (ORadj=3.08, 95% CI=1.00–9.51, p=0.05).
Adjusted analysis: non-COVID deaths 2020 compared with 
2019
For non- COVID deaths in 2020, all the BAME groups were at 
increased risk, although with broader CIs given the smaller 
number of non- COVID deaths: Asian (ORadj=1.59, 95% 
CI=0.73–3.60, p=0.26), Black (ORadj=2.27, 95% CI=0.98–
5.30, p=0.06) and Other ethnicity (ORadj=3.32, 95% 
CI=1.66–6.65, p=0.001). Among the individual comorbidi-
ties, hypertension (ORadj=1.68, 95% CI=1.03–2.74, p=0.04), 
and particularly ischaemic heart disease (ORadj=3.41, 95% 
CI=1.91–6.11, p<0.001), were significantly more likely to be 
associated with a non- COVID death in 2020 compared with 
death in 2019. There was no association with sex or depriva-
tion. With ethnicity incorporated as a binary variable, non- 
white ethnicity was significantly associated with non- COVID 
death in 2020 (ORadj=1.76, 95% CI=1.09–2.83, p=0.02).
As with COVID-19 deaths, there was a dose- dependent 
association with increasing numbers of comorbidities 
leading to a higher likelihood of death from a non- COVID 
cause in 2020, compared with deaths in 2019: baseline no 
comorbidities (OR=1.0), one comorbidity (ORadj=1.41, 95% 
CI=0.84–2.39, p=0.20), two comorbidities (ORadj=2.30, 95% 
CI=1.19–4.42, p=0.01) and three comorbidities (ORadj=6.46, 
95% CI=2.04–20.4, p=0.001).
DISCUSSION
In this analysis of a 6- week period of mortality data, 
commencing with the first COVID-19 death in in a large 
teaching hospital in London on 12th of March 2020, two 
phenomena were observed. First, the COVID-19 deaths 
rapidly escalated such that the total number of COVID-19 
deaths significantly exceeded the number of all- cause deaths 
that occurred in the same 6- week period in 2019. Second, 
the number of non- COVID deaths diminished significantly 
throughout the period, dropping to less than half of the 
usual weekly number of deaths. The latter is consistent 
with the significant reduction in patients attending emer-
gency departments with attendances having dropped by 
30% in March 2020 at the start of the COVID-19 pandemic, 
compared with March 2019.13 Notable among the reduced 
number of non- COVID deaths has been the reduction of 
deaths for specific causes, with the number of stroke deaths 
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having dropped by 60%. Assuming the rate of fatal strokes 
has remained constant, this suggests that more patients are 
dying of strokes in the community or at hospitals that may 
refer patients to our stroke unit. It is not possible from our 
data to analyse differences in referral patterns for regional 
specialty services, or indeed stroke deaths outside the 
hospital from the data evaluated. Conversely, it could be 
that the change in environmental circumstances during the 
lockdown has resulted in fewer strokes occurring.
The concern that the drop in non- COVID deaths in the 
hospital setting may be concealing a rise in such deaths in 
the community was confirmed in an independent analysis 
of the Office of National Statistic (ONS) data which demon-
strated an absolute and relative increase in non- COVID 
deaths during the pandemic.14Subsequent analysis of 
mortality data in England and Wales by the ONS themselves 
has confirmed that non- COVID-19 deaths in hospitals fell 
to significantly below the 5- year average during this period, 
whereas an excess of non- COVID-19 deaths has occurred 
in care homes and private homes.15 The ONS hypothesised 
that if patients have been discharged from hospital sooner 
than they may have been typically, because of pressure on 
the National Health Service’s (NHS) resources, this could 
have resulted in some deaths occurring in care homes 
or private homes that would have otherwise occurred in 
hospital.15 The hospital never reached a point at which 
patients could not be admitted or could not have access to 
intensive care if this was required.
Although COVID-19 deaths occurred more frequently 
in the elderly, the age distribution of deaths was very 
similar in the three groups. Hence, in our analysis there 
was no evidence that the elderly were disproportionately 
represented in the COVID-19 deaths, compared with 
non- COVID-19 deaths during the same period and also 
compared with deaths occurring in the same period in the 
previous year. A possible explanation for why we did not 
see a difference in the age distribution of deaths between 
groups within the hospital is that our data only relate to 
deaths in the hospital and not those in the community and 
a significant proportion of COVID-19 deaths in the UK is 
occurring in nursing homes or at home.
COVID-19 deaths occurred significantly more frequently 
in those of non- white ethnicity. While concern has been 
expressed that the data on ethnicity in patients with 
COVID-19 are limited,16 our observation has been repli-
cated by others.17 The degree of increase observed in our 
analyses is remarkably consistent with a recent analysis of 
NHS England mortality data for the whole of England.18 
This combined data on COVID-19 fatalities with deaths by 
ethnicity and then undertook indirect standardisation of 
these data (using the whole population of England as the 
reference) to produce ethnic- specific standardised mortality 
ratios adjusted for age and geographical region. Death from 
COVID-19 was significantly more likely in BAME groups: 
Black African (3.24; 95% CIs=2.90–3.62), Black Caribbean 
(2.21; 95% CIs=2.02–2.41), Pakistani (3.29; 95% CIs=2.96–
3.64), Bangladeshi (2.41; 95% CIs=1.98–2.91) and Indian 
(1.70; 95% CIs=1.56–1.85) minority ethnic groups.
Public Health England has undertaken a rapid review 
of the published literature, which included four studies 
describing the COVID-19 epidemic individual NHS trusts, 
to identify if inequalities exist in how BAME groups are 
affected by COVID-19 infection when compared with the 
White British population. This observed that the all- cause 
mortality was almost four times higher than expected 
among Black men, almost three times higher in Asian men 
and almost two times higher in White men.19 The review 
found that the highest age standardised diagnosis rates 
of COVID-19 per 100 000 population were in people of 
Black ethnic groups (486 in women and 649 in men) and 
the lowest were in people of White ethnic groups (220 in 
women and 224 in men).19
The increased mortality in the BAME communities has 
also been confirmed in an analysis combining general prac-
titioner records of over 17 million adults with COVID-19 
mortality data.20 Death from COVID-19 was strongly asso-
ciated with: being man (HR=1.99, 95% CI=1.88–2.10); 
older age and deprivation (both with a strong gradient); 
uncontrolled diabetes (HR=2.36 95% CI=2.18–2.56) and 
severe asthma (HR=1.25 CI=1.08–1.44). Compared with 
people with ethnicity recorded as white, black people 
were at higher risk of death, with only partial attenuation 
in HRs from the fully adjusted model (age- sex adjusted 
HR=2.17, 95% CI=1.84–2.57; fully adjusted HR=1.71, 95% 
CI=1.44–2.02); with similar findings for Asian people (age- 
sex adjusted HR=1.95, 95% CI=1.73–2.18; fully adjusted 
HR=1.62, 95% CI=1.43–1.82).
Significantly in our analysis we also find an increased 
mortality in the BAME communities from non- COVID 
causes during the early phases of the pandemic at St 
George’s Hospital. Both the COVID-19 and non- COVID 
increases in mortality were independent of comorbidities, 
sex, age and deprivation. That these other factors do not 
explain the increase leaves the outstanding question as to 
what is responsible for the increase in mortality during 
the pandemic within the BAME communities.
The comorbidity analyses demonstrate that those dying 
in 2020 at St George’s Hospital were more likely to have 
multiple morbidities. We focused on the three most 
common comorbidities and subsequent research has 
confirmed the importance of these. The principal comor-
bidity we had limited data on was obesity, largely because 
of poor recording of weight in the medical records. 
Furthermore, it would have been useful to have informa-
tion about other comorbidities such as respiratory disease. 
This suggests that potentially the patients being admitted 
to the hospital were more likely to be complex and chron-
ically ill. It maybe that there has been an ethnic variation 
in who has attended and subsequently been admitted to 
hospital during the pandemic. A history of hypertension 
was associated with both COVID-19 and non- COVID 
deaths in 2020, with diabetes mellitus a major risk factor in 
COVID-19 deaths, and a history of ischaemic heart disease 
in non- COVID deaths. Our case notes review ascertained 
pre- existing comorbidities rather than comorbidities 
acquired during the hospital admission. It is recognised 
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that COVID-19 acutely affects the kidneys21 and heart22 in 
a significant proportion of critically ill patients.
While we can compare the IMD distribution between the 
three groups, we have to infer how this relates to the IMD 
distribution of the St George’s catchment area. The IMD 
distribution of Merton is broadly consistent with the IMD 
distribution for the deaths in 2019 (group 3).23 Compared 
with the 2019 deaths, those living in more deprived areas 
were over- represented among the COVID-19 deaths, consis-
tent with national data associating poverty with increased 
likelihood of death from COVID-19 disease. The associa-
tion was statistically significant in univariate analysis but 
not in the adjusted analysis. All- cause mortality increases 
with increasing deprivation. A recent ONS analysis has 
shown that over and above this stepwise association with 
increasing poverty, COVID-19 deaths are over- represented 
in the top three deciles of deprivation.24 Hence, the 
absence of detecting a stronger signal between deprivation 
and COVID-19 mortality in the St George’s data, is likely to 
reflect the paucity of the most deprived areas in our catch-
ment area.
In a recent analysis of 16 749 patients with COVID-19 
admitted to 166 UK hospitals between 6th of February 
and 18th of April, the most common comorbidities were 
chronic cardiac disease (29%), uncomplicated diabetes 
(19%), non- asthmatic chronic pulmonary disease (19%) 
and asthma (14%), with 47% having no documented 
comorbidity.25 The median age of admissions was 72 years 
and of deaths was 80 years, and 60% were men. The excess 
of male deaths was confirmed, as was the association of 
diabetes and chronic cardiac disease with increased risk 
of mortality from COVID-19. The analysis did not refer to 
ethnicity.25
This paper describes a comprehensive analysis of 
the early phases of the COVID-19 pandemic in a major 
London teaching hospital. The strengths of our study 
are that the data were acquired prospectively through 
medical examiner case review and all patients who 
had a positive COVID-19 swab were captured in the 
COVID-19 group. COVID-19- associated deaths may 
have been very slightly underestimated in the context 
of possible false negative swabs, or in patients who died 
prior to a swab being taken. It is unlikely that the in- hos-
pital non- COVID deaths are underestimated, although 
some patients in the COVID-19 group may have 
died with, rather than of, COVID-19. Importantly, St 
George’s Hospital serves a population of rich diversity 
and declared ethnicity data were derived from patient 
and family reporting.
This study was limited by the relatively small numbers 
in a single centre, and the methodology focusing on 
in- hospital deaths alone. The study was not designed 
to evaluate the characteristics of survivors of COVID-
19. We were not able to determine whether there were 
differences in sociocultural determinants of attendance 
behaviour between ethnic groups, or indeed differ-
ences in those who survived COVID-19 and clinical 
records do not consistently record this information. 
The recommendations of the Public Health England 
report include improving the comprehensiveness and 
quality of ethnicity data collection and recording, as 
well as improving access, experiences and outcomes of 
NHS services by BAME communities.19
Medical examiners have the ability to contribute to 
future research through their timely review of clinical 
records, consistency of data recording and their role 
enabling them to gain further insights from bereaved 
families. Individual case review, such as what took 
place in this analysis, may help facilitate distinguishing 
between death being directly caused by COVID-19 as 
opposed to it being a contributor.
CONCLUSIONS
Analysis of COVID-19 deaths at St George’s demon-
strated a similar age distribution to deaths normally 
observed in the hospital. In contrast, BAME communi-
ties are disproportionately affected by COVID-19 and 
non- COVID deaths, and the excess in mortality in the 
BAME groups remains after adjustment and is not fully 
explained by available hospital information on comor-
bidities, age, sex or poverty.
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